Sandoz launches topical psoriasis treatment

PRINCETON, N.J. Sandoz has launched its version of a topical drug used to treat psoriasis of the scalp, the Swiss generic drug maker announced Thursday.

The company launched calcipotriene solution in the 0.005% strength, a synthetic vitamin D3 derivative and generic version of Leo Pharma’s Dovonex Scalp Solution. The drug is used to treat moderately severe chronic psoriasis of the scalp.

Branded and generic versions of Dovonex had sales of $12.2 million during the 12-month period ended in September, according to IMS Health.